Showing results (131-140 of 356) with videos related to
Sort By:
Pageof 36
Clinical Pharmacokinetics|January 23, 2016
A Comprehensive Review of Novel Drug-Disease Models in Diabetes Drug DevelopmentPuneet Gaitonde, Parag Garhyan, Catharina Link, et al.Pharmaceutics|November 27, 2021
In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B against Candida aurisUnai Caballero, Elena Eraso, Javier Pemán, et al.Plant Physiology and Biochemistry : PPB|October 13, 2017
Combined effects of fungal inoculants and the cytokinin-like growth regulator thidiazuron on growth, phytohormone contents and endophytic root fungi in Miscanthus × giganteusChristoph Stephan Schmidt, Libor Mrnka, Tomaš Frantík, et al.Pharmaceutics|January 28, 2026
Translational Model to Predict Lung and Prostate Distribution of Levofloxacin in HumansEstevan Sonego Zimmermann, Teresa Dalla Costa, Brian Cicali, et al.Journal of Leukocyte Biology|December 6, 2003
Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patientsStephan Schmidt, Edin Moric, Martina Schmidt, et al.International Journal of Antimicrobial Agents|April 3, 2009
Pharmacokinetic/pharmacodynamic modelling and in vitro simulation of dynamic voriconazole-Candida interactionsYanjun Li, M Hong Nguyen, Stephan Schmidt, et al.Antibiotics (Basel, Switzerland)|April 3, 2021
In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida aurisUnai Caballero, Sarah Kim, Elena Eraso, et al.Clinical Pharmacology and Therapeutics|April 24, 2024
Leveraging QSP Models for MIPD: A Case Study for Warfarin/INRUndine Falkenhagen, Larisa H Cavallari, Julio D Duarte, et al.European Journal of Medicinal Chemistry|November 12, 2025
From tetrazole to isoquinolinone: Structure-based optimization and late-stage diversification of AR-C118925-derived P2Y2 receptor antagonistsRayan Aboalgasim Makawi Abdalrahman, Katja Schlegel, Victor Hugo Catricala Fernandes, et al.Antimicrobial Agents and Chemotherapy|September 30, 2009
Pharmacokinetic-pharmacodynamic modeling of the in vitro activities of oxazolidinone antimicrobial agents against methicillin-resistant Staphylococcus aureusStephan Schmidt, Sreedharan Nair Sabarinath, April Barbour, et al.Pageof 36